227 related articles for article (PubMed ID: 2839658)
21. Morphine exerts testosterone-like effects in the hypothalamus of the castrated male rat.
Cicero TJ; Meyer ER; Gabriel SM; Bell RD; Wilcox CE
Brain Res; 1980 Nov; 202(1):151-64. PubMed ID: 7427731
[TBL] [Abstract][Full Text] [Related]
22. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists.
Matsumoto RR; Brinsfield KH; Patrick RL; Walker JM
J Pharmacol Exp Ther; 1988 Jul; 246(1):196-203. PubMed ID: 2839661
[TBL] [Abstract][Full Text] [Related]
23. Suppressive effect of morphine on serum gonadotropin levels in castrated rats.
Muraki T; Tokunaga Y; Nakadate T; Kato R
Arch Int Pharmacodyn Ther; 1980 Aug; 246(2):324-34. PubMed ID: 6776920
[TBL] [Abstract][Full Text] [Related]
24. Opiate-mediated control of luteinizing hormone in the male: role in the development of narcotic tolerance and physical dependence.
Cicero TJ
NIDA Res Monogr; 1984; 54():184-208. PubMed ID: 6099873
[No Abstract] [Full Text] [Related]
25. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
Asensio VJ; Miralles A; García-Sevilla JA
Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
[TBL] [Abstract][Full Text] [Related]
26. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
27. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
Millan MJ; Morris BJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
[TBL] [Abstract][Full Text] [Related]
28. Endocrine actions of opioids.
Pfeiffer A; Herz A
Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
[TBL] [Abstract][Full Text] [Related]
29. Ageing of the neuroendocrine system in the brain of male rats: receptor mechanisms and steroid metabolism.
Piva F; Celotti F; Dondi D; Limonta P; Maggi R; Messi E; Negri-Cesi P; Zanisi M; Motta M; Martini L
J Reprod Fertil Suppl; 1993; 46():47-59. PubMed ID: 8391083
[TBL] [Abstract][Full Text] [Related]
30. Predominant involvement of mu-rather than delta- or kappa-opiate receptors in LH secretion.
Pfeiffer DG; Pfeiffer A; Shimohigashi Y; Merriam GR; Loriaux DL
Peptides; 1983; 4(5):647-9. PubMed ID: 6318200
[TBL] [Abstract][Full Text] [Related]
31. Endogenous opioids participate in the regulation of the hypothalamus-pituitary-luteinizing hormone axis and testosterone's negative feedback control of luteinizing hormone.
Cicero TJ; Schainker BA; Meyer ER
Endocrinology; 1979 May; 104(5):1286-91. PubMed ID: 374068
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
Lester PA; Traynor JR
Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
[TBL] [Abstract][Full Text] [Related]
33. Morphine-induced supersensitivity to the effects of naloxone on luteinizing hormone secretion in the male rat.
Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
J Pharmacol Exp Ther; 1983 Apr; 225(1):35-41. PubMed ID: 6682144
[TBL] [Abstract][Full Text] [Related]
34. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
35. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
Cohen ML; Mendelsohn LG; Mitch CH; Zimmerman DM
Receptor; 1994; 4(1):43-53. PubMed ID: 8038706
[TBL] [Abstract][Full Text] [Related]
36. A kappa opioid effect: increased urination in the rat.
Leander JD
J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
[TBL] [Abstract][Full Text] [Related]
37. Acute reductions in serum testosterone levels by narcotics in the male rat: stereospecificity, blockade by naloxone and tolerance.
Cicero TJ; Wilcox CE; Bell RD; Meyer ER
J Pharmacol Exp Ther; 1976 Aug; 198(2):340-6. PubMed ID: 948030
[TBL] [Abstract][Full Text] [Related]
38. Opiatergic control of gonadotropin secretion during puberty in the rat: a neurochemical basis for the hypothalamic 'gonadostat'?
Bhanot R; Wilkinson M
Endocrinology; 1983 Aug; 113(2):596-603. PubMed ID: 6409589
[TBL] [Abstract][Full Text] [Related]
39. Age- and sex-specific changes in naloxone-induced luteinizing hormone secretion and Fos expression in gonadotropin-releasing hormone neurons of gonadectomized rats.
Funabashi T; Furuta M; Fukushima A; Kimura F
Neurosci Lett; 2010 Mar; 471(3):157-61. PubMed ID: 20097261
[TBL] [Abstract][Full Text] [Related]
40. In vivo evidence for a direct effect of naloxone on testicular steroidogenesis in the male rat.
Cicero TJ; Adams ML; O'Connor LH; Nock B
Endocrinology; 1989 Aug; 125(2):957-63. PubMed ID: 2666108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
